References
- BurnstockGPathophysiology and therapeutic potential of purinergic signalingPharmacol Rev200658 58 86 1:CAS:528:DC%2BD28XjtlCqsLo%3D https://doi.org/10.1124/pr.58.1.5 16507883
- BoursMJSwennenELDi VirgilioFCronsteinBNDagneliePCAdenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammationPharmacol Ther2006112 358 404 1:CAS:528:DC%2BD28XhtVGjt7vF https://doi.org/10.1016/j.pharmthera.2005.04.013 16784779
- ChoiHKAtkinsonKKarlsonEWWillettWCurhanGPurine-rich foods, dairy and protein intake, and the risk of gout in menN Engl J Med2004350 1093 1103 1:CAS:528:DC%2BD2cXitV2qur4%3D https://doi.org/10.1056/NEJMoa035700 15014182
- DuchenKThorellLNucleotide and polyamine levels in colostrum and mature milk in relation to maternal atopy and atopic development in the childrenActa Paediatr199988 1338 1343 1:STN:280:DC%2BD3c%2FovF2ntg%3D%3D https://doi.org/10.1111/j.1651-2227.1999.tb01047.x 10626518
- CarverJDPimentelBCoxWIBarnessLADietary nucleotide effects upon immune function in infantsPediatrics199188 359 363 1:STN:280:DyaK3MzhvFCqtg%3D%3D 1861940
- JordanANJurcaRAbrahamEHSalikhovaAMannJKMorssGMChurchTSLuciaAEarnestCPEffects of oral ATP supplementation on anaerobic power and muscular strengthMed Sci Sports Exerc200436 983 990 1:CAS:528:DC%2BD2cXksF2lsrc%3D https://doi.org/10.1249/01.MSS.0000128198.97260.8B 15179168
- BannwarthBAllaertFAAvouacBRossignolMRozenbergSValatJPA randomized, double-blind, placebo controlled study of oral adenosine triphosphate in subacute low back painJ Rheumatol200532 1114 1117 1:CAS:528:DC%2BD2MXmtValur4%3D 15940776
- RossignolMAllaertFARozenbergSValatJPAvouacBPeresGLe TeuffGBannwarthBMeasuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trialPharmacoepidemiol Drug Saf200514 861 867 1:CAS:528:DC%2BD28Xot1ensQ%3D%3D https://doi.org/10.1002/pds.1114 15991263
- HerdaTJRyanEDStoutJRCramerJTEffects of a supplement designed to increase ATP levels on muscle strength, power output, and enduranceJ Int Soc Sports Nutr20085 3 2253504 https://doi.org/10.1186/1550-2783-5-3 18230170
- KicheninKDecollogneSAngignardJSemanMCardiovascular and pulmonary response to oral administration of ATP in rabbitsJ Appl Physiol200088 1962 1968 1:CAS:528:DC%2BD3cXksFWqsLs%3D https://doi.org/10.1063/1.1305828 10846006
- KicheninKSemanMDecollogneSAngignardJChronic oral administration of ATP modulates nucleoside transport and purine metabolism in ratsJ Pharmacol Exp Ther2000294 126 133 1:CAS:528:DC%2BD3cXksFyht7c%3D 10871303
- Pastor-AngladaMErrasti-MurugarrenEAymerichICasadoFJConcentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signalingJ Physiol Biochem200763 97 110 1:CAS:528:DC%2BD2sXhtVOrsL%2FF https://doi.org/10.1007/BF03174089 17722647
- AgtereschHJDagneliePCRietveldTvan den BergJWDanserAHWilsonJHPharmacokinetics of intravenous ATP in cancer patientsEur J Clin Pharmacol200056 49 55 1:CAS:528:DC%2BD3cXisVOjs7c%3D https://doi.org/10.1007/s002280050719 10853877
- HuyghebaertNVermeireARemonJPIn vitro evaluation of coating polymers for enteric coating and human ileal targetingInt J Pharm2005298 26 37 1:CAS:528:DC%2BD2MXlsVCktr0%3D https://doi.org/10.1016/j.ijpharm.2005.03.032 15894443
- CoolenEJCMArtsICWSwennenELRBastACohen StuartMADagneliePCSimultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detectionJ Chromatogr B2008864 43 51 1:CAS:528:DC%2BD1cXjtlCisLo%3D https://doi.org/10.1016/j.jchromb.2008.01.033
- MarcusAJBroekmanMJDrosopoulosJHIslamNAlyonychevaTNSafierLBHajjarKAPosnettDNSchoenbornMASchooleyKA et al The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39J Clin Invest199799 1351 1360 507951 1:CAS:528:DyaK2sXitVWmtbk%3D https://doi.org/10.1172/JCI119294 9077545
- TrappGAMatrix modifiers in graphite furnace atomic absorption analysis of trace lithium in biological fluidsAnal Biochem1985148 127 132 1:CAS:528:DyaL2MXktlWqsrk%3D https://doi.org/10.1016/0003-2697(85)90637-2 4037295
- HaskellCMWongMWilliamsALeeLYPhase I trial of extracellular adenosine 5′-triphosphate in patients with advanced cancerMed Pediatr Oncol199627 165 173 1:STN:280:DyaK28zis1OisQ%3D%3D https://doi.org/10.1002/(SICI)1096-911X(199609)27:3<165::AID-MPO6>3.0.CO;2-C 8699994
- AgtereschHJRietveldTKerkhofsLGvan den BergJWWilsonJHDagneliePCBeneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trialJ Clin Oncol200220 371 378 1:CAS:528:DC%2BD38XovVKisA%3D%3D https://doi.org/10.1200/JCO.20.2.371 11786563
- YegutkinGGNucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascadeBiochim Biophys Acta20081783 673 694 1:CAS:528:DC%2BD1cXkvVOgsrs%3D https://doi.org/10.1016/j.bbamcr.2008.01.024 18302942
- StrohmeierGRLencerWIPatapoffTWThompsonLFCarlsonSLMoeSJCarnesDKMrsnyRJMadaraJLSurface expression, polarization, and functional significance of CD73 in human intestinal epitheliaJ Clin Invest199799 2588 2601 508104 1:CAS:528:DyaK2sXjs1Knt7k%3D https://doi.org/10.1172/JCI119447 9169488
- MohamedaliKAGuicheritOMKellemsRERudolphFBThe highest levels of purine catabolic enzymes in mice are present in the proximal small intestineJ Biol Chem1993268 23728 23733 1:CAS:528:DyaK3sXlslyjt7w%3D 8226898
- NgoLYPatilSDUnadkatJDOntogenic and longitudinal activity of Na(+)-nucleoside transporters in the human intestineAm J Physiol Gastrointest Liver Physiol2001280 G475 G481 1:CAS:528:DC%2BD3MXjtVWqsbk%3D 11171631
- GriffithDAJarvisSMNucleoside and nucleobase transport systems of mammalian cellsBiochim Biophys Acta19961286 153 181 1:CAS:528:DyaK28XmvFals7s%3D https://doi.org/10.1016/S0304-4157(96)00008-1 8982282
- FoxIHMetabolic basis for disorders of purine nucleotide degradationMetabolism198130 616 634 1:CAS:528:DyaL3MXitVKmsLc%3D https://doi.org/10.1016/0026-0495(81)90142-6 6262603
- HuyghebaertNVermeireARottiersPRemautERemonJPDevelopment of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactisEur J Pharm Biopharm200561 134 141 1:CAS:528:DC%2BD2MXhtFWhtrjO https://doi.org/10.1016/j.ejpb.2005.04.002 15967652
- GreenbergGRFeaganBGMartinFSutherlandLRThomsonABWilliamsCNNilssonLGPerssonTOral budesonide for active Crohn’s disease. Canadian Inflammatory Bowel Disease Study GroupN Engl J Med1994331 836 841 1:STN:280:DyaK2czlvFGntg%3D%3D https://doi.org/10.1056/NEJM199409293311303 8078529
- HuLDLiuYTangXZhangQPreparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pelletsEur J Pharm Biopharm200664 185 192 1:CAS:528:DC%2BD28XptlyktLc%3D https://doi.org/10.1016/j.ejpb.2006.04.004 16797948
- The United States Pharmacopeia. 1999, The United States Pharmacopeial Convention I, Rockville ed
- DavisSSHardyJGFaraJWTransit of pharmaceutical dosage forms through the small intestineGut198627 886 892 1433369 1:STN:280:DyaL283ns1WmtA%3D%3D https://doi.org/10.1136/gut.27.8.886 3732895
- HoltmannGKellyDGSternbyBDiMagnoEPSurvival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymesAm J Physiol1997273 G553 G558 1:CAS:528:DyaK2sXlslegs74%3D 9277437
- FallingborgJPedersenPJacobsenBASmall intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn’s diseaseDig Dis Sci199843 702 705 1:STN:280:DyaK1c3hslWjtg%3D%3D https://doi.org/10.1023/A:1018893409596 9558022
- WashingtonNWashingtonCWilsonCG WilsonCGChapter 7: Drug delivery to the large intestine and rectumPhysiological Pharmaceutics2001 2 London Taylor & Francis
- de RoosNMde VriesJHKatanMBSerum lithium as a compliance marker for food and supplement intakeAm J Clin Nutr200173 75 79 1:CAS:528:DC%2BD3MXitVSktg%3D%3D 11124753
- Muller-OerlinghausenBBerghoferABauerMBipolar disorderLancet2002359 241 247 https://doi.org/10.1016/S0140-6736(02)07450-0 11812578
- MazzaliMHughesJKimYGJeffersonJAKangDHGordonKLLanHYKivlighnSJohnsonRJElevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanismHypertension200138 1101 1106 1:CAS:528:DC%2BD3MXovVOrsbg%3D https://doi.org/10.1161/hy1101.092839 11711505
- SelbyJVFriedmanGDQuesenberryCPPrecursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistriesAm J Epidemiol1990131 1017 1027 1:STN:280:DyaK3c3mtFKrtw%3D%3D 2343854
- BosMJKoudstaalPJHofmanAWittemanJCBretelerMMUric acid is a risk factor for myocardial infarction and stroke: the Rotterdam studyStroke200637 1503 1507 1:CAS:528:DC%2BD28Xksl2is7g%3D https://doi.org/10.1161/01.STR.0000221716.55088.d4 16675740
- ShojiAYamanakaHKamataniNA retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapyArthritis Rheum200451 321 325 1:CAS:528:DC%2BD2cXls1Sjtr4%3D https://doi.org/10.1002/art.20405 15188314
- SnaithMLScottJTUric acid clearance in patients with gout and normal subjectsAnn Rheum Dis197130 285 289 1005769 1:STN:280:DyaE3M3jtVKgug%3D%3D https://doi.org/10.1136/ard.30.3.285 5090245
- SchumacherHRThe pathogenesis of goutCleve Clin J Med200875 Suppl 5 S2 S4 https://doi.org/10.3949/ccjm.75.Suppl_5.S2 18822468
- AmesBNCathcartRSchwiersEHochsteinPUric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesisProc Natl Acad Sci U S A198178 6858 6862 349151 1:CAS:528:DyaL38Xks1Gg https://doi.org/10.1073/pnas.78.11.6858 6947260
- WatanabeSKangDHFengLNakagawaTKanellisJLanHMazzaliMJohnsonRJUric acid, hominoid evolution, and the pathogenesis of salt-sensitivityHypertension200240 355 360 1:CAS:528:DC%2BD38XntVKrsL0%3D https://doi.org/10.1161/01.HYP.0000028589.66335.AA 12215479
- ChenHMosleyTHAlonsoAHuangXPlasma urate and Parkinson’s disease in the Atherosclerosis Risk in Communities (ARIC) studyAm J Epidemiol2009169 1064 1069 2727240 https://doi.org/10.1093/aje/kwp033 19299404
- AscherioALeWittPAXuKEberlySWattsAMatsonWRMarrasCKieburtzKRudolphABogdanovMB et al Urate as a predictor of the rate of clinical decline in Parkinson diseaseArch Neurol200966 1460 1468 2795011 https://doi.org/10.1001/archneurol.2009.247 19822770
- MarkowitzCESpitsinSZimmermanVJacobsDUdupaJKHooperDCKoprowskiHThe treatment of multiple sclerosis with inosineJ Altern Complement Med200915 619 625 3189001 https://doi.org/10.1089/acm.2008.0513 19425822